Isocitrate dehydrogenase mutations in myeloid malignancies

por Medeiros, B C, Fathi, A T, DiNardo, C D, Pollyea, D A, Chan, S M, Swords, R
Publicado 2017

European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell trans...

por Medeiros, B C, Tian, L, Robenson, S, Laport, G G, Johnston, L J, Shizuru, J A, Miklos, D B, Arai, S, Benjamin, J E, Weng, W-K, Negrin, R S, Lowsky, R
Publicado 2014

Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes

por Swords, R T, Watts, J, Erba, H P, Altman, J K, Maris, M, Anwer, F, Hua, Z, Stein, H, Faessel, H, Sedarati, F, Dezube, B J, Giles, F J, Medeiros, B C, DeAngelo, D J
Publicado 2017